Skip to main content Accessibility help
×
Hostname: page-component-5f745c7db-hj587 Total loading time: 0 Render date: 2025-01-06T23:43:57.608Z Has data issue: true hasContentIssue false

Chapter 16 - Depressive Disorders

Published online by Cambridge University Press:  02 January 2025

Marsal Sanches
Affiliation:
McGovern Medical School, Texas
Jair C. Soares
Affiliation:
McGovern Medical School, Texas
Get access

Summary

Depressive disorders are responsible for significant morbidity and functional impairment worldwide. This chapter provides an overview of the many depressive disorders encountered in clinical practice. It includes their classification, clinical presentation, diagnostic criteria, and epidemiological aspects. Considerations about the pathophysiological factors involved in depressive disorder and their treatment are also included.

Type
Chapter
Information
Fundamentals of Clinical Psychiatry
A Practical Handbook
, pp. 145 - 157
Publisher: Cambridge University Press
Print publication year: 2025

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Pluta, R. M., Development of lifetime comorbidity in the World Health Organization world mental health surveys. 305 (2011), 870.Google Scholar
Boland, R., Verdiun, M., Ruiz, P., Kaplan and Sadock’s Synopsis of Psychiatry, Twelfth edition. (Philadelphia: Wolters Kluwer Health, 2021).Google Scholar
Hasin, D. S., Sarvet, A. L., Meyers, J. L., Saha, T. D., Ruan, W. J., Stohl, M., Grant, B. F., Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. 75 (2018), 336–346. https://doi.org/10.1001/jamapsychiatry.2017.4602.CrossRefGoogle Scholar
Diagnostic and statistical manual of mental disorders: DSM-5-TR, 5th edition, text revision. (Washington, DC: American Psychiatric Association Publishing, 2022).Google Scholar
Solomon, D. A., Keller, M. B., Leon, A. C., Mueller, T. I., Lavori, P. W., Shea, M. T., Coryell, W., Warshaw, M., Turvey, C., Maser, J. D., Endicott, J., Multiple recurrences of major depressive disorder. 157 (2000), 229–233. https://doi.org/10.1176/appi.ajp.157.2.229.CrossRefGoogle Scholar
Caddy, C., Giaroli, G., White, T. P., Shergill, S. S., Tracy, D. K., Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy. 4 (2014), 75–99. https://doi.org/10.1177/2045125313507739.CrossRefGoogle Scholar
Morilak, D. A., Frazer, A., Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders. 7 (2004), 193–218. https://doi.org/10.1017/S1461145704004080.CrossRefGoogle Scholar
Sanacora, G., Treccani, G., Popoli, M., Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. 62 (2012), 63–77. https://doi.org/10.1016/j.neuropharm.2011.07.036.CrossRefGoogle Scholar
Arciniegas, D. B, Yudofsky, S. C, Hales, R. E, Textbook of Neuropsychiatry and Clinical Neurosciences, Sixth edition (Washington, DC: American Psychiatric Association Publishing, 2018).Google Scholar
Pariante, C. M., Lightman, S. L., The HPA axis in major depression: classical theories and new developments. 31 (2008), 464–468. https://doi.org/10.1016/j.tins.2008.06.006.CrossRefGoogle Scholar
Heim, C., Binder, E. B., Current research trends in early life stress and depression: review of human studies on sensitive periods, gene–environment interactions, and epigenetics. 233 (2012), 102–111. https://doi.org/10.1016/j.expneurol.2011.10.032.CrossRefGoogle Scholar
McNamara, R. K., Lotrich, F. E., Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target? 12 (2012), 1143–1161. https://doi.org/10.1586/ern.12.98.CrossRefGoogle Scholar
Rosenblat, J. D., Cha, D. S., Mansur, R. B., McIntyre, R. S., Inflamed moods: a review of the interactions between inflammation and mood disorders. 53 (2014), 23–34. https://doi.org/10.1016/j.pnpbp.2014.01.013.CrossRefGoogle Scholar
Wise, T., Cleare, A. J., Herane, A., Young, A. H., Arnone, D., Diagnostic and therapeutic utility of neuroimaging in depression: an overview. 10 (2014), 1509–1522. https://doi.org/10.2147/NDT.S50156.CrossRefGoogle Scholar
Levinson, D. F., The genetics of depression: a review. 60 (2006), 84–92. https://doi.org/10.1016/j.biopsych.2005.08.024.CrossRefGoogle Scholar
Montgomery, S. A., Åsberg, M., A new depression scale designed to be sensitive to change. 134 (1979), 382-389. https://doi.org/10.1192/bjp.134.4.382.CrossRefGoogle Scholar
Hamilton, M., A rating scale for depression. 23 (1960), 56–62. https://doi.org/10.1136/jnnp.23.1.56.CrossRefGoogle Scholar
Cleare, A., Pariante, C. M., Young, A. H., Anderson, I. M., Christmas, D., Cowen, P. J., Dickens, C., Ferrier, I. N., Geddes, J., Gilbody, S., Haddad, P. M., Katona, C., Lewis, G., Malizia, A., McAllister-Williams, R. H., Ramchandani, P., Scott, J., Taylor, D., Uher, R., Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines. 29 (2015), 459–525. https://doi.org/10.1177/0269881115581093.CrossRefGoogle Scholar
Bauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H. J., World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders. 14 (2013), 334–385. https://doi.org/10.3109/15622975.2013.804195.CrossRefGoogle Scholar
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., McGrath, P. J., Rosenbaum, J. F., Sackeim, H. A., Kupfer, D. J., Luther, J., Fava, M., Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STARD report. 163 (2006), 1905–1917. https://doi.org/10.1176/ajp.2006.163.11.1905.CrossRefGoogle Scholar
Cuijpers, P., Dekker, J., Hollon, S. D., Andersson, G., Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis. 70 (2009), 1219–1229. https://doi.org/10.4088/JCP.09r05021.CrossRefGoogle Scholar
Cuijpers, P., van Straten, A., Warmerdam, L., Andersson, G., Psychotherapy versus the combination of psychotherapy and pharmacotherapy in the treatment of depression: a meta-analysis. 26 (2009), 279–288. https://doi.org/10.1002/da.20519.CrossRefGoogle Scholar
Kupfer, D. J., Frank, E., Phillips, M. L., Major depressive disorder: new clinical, neurobiological, and treatment perspectives. 379 (2012), 1045–1055. https://doi.org/10.1016/s0140–6736(11)60602-8.CrossRefGoogle Scholar
Cuijpers, P., Reynolds, C. F., 3rd, Donker, T., Li, J., Andersson, G., Beekman, A., Personalized treatment of adult depression: medication, psychotherapy, or both? A systematic review. 29 (2012), 855–864. https://doi.org/10.1002/da.21985.CrossRefGoogle Scholar
Marcus, S. C., Olfson, M., National trends in the treatment for depression from 1998 to 2007. 67 (2010), 1265–1273. https://doi.org/10.1001/archgenpsychiatry.2010.151.CrossRefGoogle Scholar
Mojtabai, R., Olfson, M., National patterns in antidepressant treatment by psychiatrists and general medical providers: results from the national comorbidity survey replication. 69 (2008), 1064–1074. https://doi.org/10.4088/jcp.v69n0704.CrossRefGoogle Scholar
Spijker, J., Nolen, W. A., An algorithm for the pharmacological treatment of depression. 121 (2010), 180–189. https://doi.org/10.1111/j.1600-0447.2009.01492.x.CrossRefGoogle Scholar
Simon, G. E., Perlis, R. H., Personalized medicine for depression: can we match patients with treatments? 167 (2010), 1445–1455. https://doi.org/10.1176/appi.ajp.2010.09111680.CrossRefGoogle Scholar
Gartlehner, G., Hansen, R. A., Morgan, L. C., Thaler, K., Lux, L., Van Noord, M., Mager, U., Thieda, P., Gaynes, B. N., Wilkins, T., Strobelberger, M., Lloyd, S., Reichenpfader, U., Lohr, K. N., Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis. 155 (2011), 772–785. https://doi.org/10.7326/0003-4819-155-11-201112060-00009.CrossRefGoogle Scholar
Gartlehner, G., Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: An Update of the 2007 Comparative Effectiveness Review. (Rockville, MD: Agency for Healthcare Research and Quality, 2011).Google ScholarPubMed
Gartlehner, G., Thaler, K., Hill, S., Hansen, R. A., How should primary care doctors select which antidepressants to administer? 14 (2012), 360–369. https://doi.org/10.1007/s11920–012-0283-x.CrossRefGoogle Scholar
Papakostas, G. I., Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder. 70 Suppl 6 (2009), 16–25. https://doi.org/10.4088/JCP.8133su1c.03.CrossRefGoogle Scholar
Fava, M., Diagnosis and definition of treatment-resistant depression. 53 (2003), 649–659. https://doi.org/10.1016/s0006–3223(03)00231-2.CrossRefGoogle Scholar
McIntyre, R. S., When should you move beyond first-line therapy for depression? 71 Suppl 1 (2010), 16–20. https://doi.org/10.4088/JCP.9104su1c.03.CrossRefGoogle Scholar
Cuijpers, P., Karyotaki, E., Weitz, E., Andersson, G., Hollon, S. D., van Straten, A., The effects of psychotherapies for major depression in adults on remission, recovery and improvement: a meta-analysis. 159 (2014), 118–126. https://doi.org/10.1016/j.jad.2014.02.026.CrossRefGoogle Scholar
Shinohara, K., Honyashiki, M., Imai, H., Hunot, V., Caldwell, D. M., Davies, P., Moore, T. H., Furukawa, T. A., Churchill, R., Behavioural therapies versus other psychological therapies for depression. 2013 (2013), Cd008696. https://doi.org/10.1002/14651858.CD008696.pub2.CrossRefGoogle Scholar
Cuijpers, P., van Straten, A., Andersson, G., van Oppen, P., Psychotherapy for depression in adults: a meta-analysis of comparative outcome studies. 76 (2008), 909–922. https://doi.org/10.1037/a0013075.CrossRefGoogle Scholar
Stahl, S. M, Grady, M. M, Stahl’s Essential Psychopharmacology: Prescriber’s Guide, Seventh edition (Cambridge: Cambridge University Press, 2020).CrossRefGoogle Scholar
Cuijpers, P., van Straten, A., Schuurmans, J., van Oppen, P., Hollon, S. D., Andersson, G., Psychotherapy for chronic major depression and dysthymia: a meta-analysis. 30 (2010), 51–62. https://doi.org/10.1016/j.cpr.2009.09.003.CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×